Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
QuintilesIMS
Harvard Business School
Queensland Health
Accenture
Teva
Express Scripts
Moodys
Merck

Generated: February 19, 2018

DrugPatentWatch Database Preview

BUSPAR Drug Profile

« Back to Dashboard

When do Buspar patents expire, and when can generic versions of Buspar launch?

Buspar is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in BUSPAR is buspirone hydrochloride. There are eighteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Drug patent expirations by year for BUSPAR
Medical Subject Heading (MeSH) Categories for BUSPAR

US Patents and Regulatory Information for BUSPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-001 Dec 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-003 Apr 22, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-004 Dec 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-004 Apr 22, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-002 Dec 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-003 Dec 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-002 Sep 29, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-001 Sep 29, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for BUSPAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-003 Apr 22, 1996 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-004 Apr 22, 1996 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-001 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride CAPSULE;ORAL 021190-004 Dec 20, 2000 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-002 Sep 29, 1986 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-004 Apr 22, 1996 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-003 Apr 22, 1996 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-001 Sep 29, 1986 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-001 Sep 29, 1986 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb BUSPAR buspirone hydrochloride TABLET;ORAL 018731-002 Sep 29, 1986 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Cerilliant
Boehringer Ingelheim
Moodys
Dow
Baxter
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot